Mandibular Osteomyelitis Associated with Candida Albicans in Marijuana and Heroin Abusers

Mikhail Daya Attie1, Isabella Alessandra Anderson2, Jason Portnof3

  • 1Broward Health Medical Center, Nova Southeastern University, Fort Lauderdale, FL, USA.

Insights

Fungal infections like Candida albicans can cause mandibular osteomyelitis in immunocompromised patients with substance abuse history. Early identification and antifungal treatment are crucial for resolution when antibiotics fail.

Area of Science:

  • Oral and Maxillofacial Surgery
  • Infectious Diseases
  • Mycology

Background:

  • Mandibular osteomyelitis is typically bacterial, but fungal infections, particularly Candida, can occur in immunocompromised individuals.
  • Substance abuse, including marijuana and opioids, can compromise the immune system, increasing infection risks.
  • Candida albicans, a common commensal, can cause opportunistic infections in susceptible patients.

Observation:

  • Two cases of mandibular osteomyelitis post-dental extraction in patients with a history of heroin and marijuana abuse are presented.
  • Infections were resistant to multiple antibiotic treatments.
  • Cultures revealed Candida albicans species.

Findings:

  • Surgical intervention (irrigation/debridement or resection) combined with antimicrobial therapy and fluconazole led to complete resolution.
  • Fungal cultures and sensitivity testing are vital for patients unresponsive to broad-spectrum antibiotics.
  • Antifungal treatment, such as oral fluconazole, is indicated for confirmed fungal infections.

Implications:

  • Clinicians must consider fungal etiologies in mandibular osteomyelitis, especially in immunocompromised patients with substance abuse histories.
  • Prompt diagnosis and targeted antifungal therapy are essential for successful treatment outcomes.
  • This case series highlights the importance of comprehensive microbiological evaluation in refractory osteomyelitis cases.